Synergism by individual macronutrients explains the marked early GLP-1 and islet hormone responses to mixed meal challenge in mice

Regulatory Peptides

Volumn 178, Issue 1-3, 2012, Pages 29-35

  Ahlkvist, L ^a   Vikman, J ^a   Pacini, G ^b   Ahren B ^a  

^a LUND UNIVERSITY   (Sweden)

^b CNR   (Italy)

Author keywords

GLP 1; Incretin; Insulin; Macronutrients; Mixed meal

Indexed keywords

GLUCAGON LIKE PEPTIDE 1;

ANIMAL EXPERIMENT; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HORMONE RESPONSE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SENSITIVITY; MACRONUTRIENT; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; AREA UNDER CURVE; BLOOD GLUCOSE; DIET; FEMALE; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; GLUCOSE TOLERANCE TEST; INCRETINS; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; LINEAR MODELS; MICE; MICE, INBRED C57BL; MILK PROTEINS; PLANT OILS;

ARACHIS HYPOGAEA; MUS;

EID: 84865383561     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2012.06.004     Document Type: Article

References (43)

1. Pacini G., Mari A. Methods for clinical assessment of insulin sensitivity and beta-cell function. Best Pract Res Clin Endocrinol Metab 2003, 17:305-322.
2. Deacon C.F. What do we know about the secretion and degradation of incretin hormones?. Regul Pept 2005, 128:117-124.
3. Maggs D., MacDonald I., Nauck M.A. Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes. Diabetes Obes Metab 2008, 10:18-33.
4. Perley M.J., Kipnis D.M. Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J Clin Invest 1967, 46:1954-1962.
5. Ma J., Rayner C.K., Jones K.L., Horowitz M. Insulin secretion in healthy subjects and patients with Type 2 diabetes-role of the gastrointestinal tract. Best Pract Res Clin Endocrinol Metab 2009, 23:413-424.
6. Horowitz M., Nauck M.A. To be or not to be-an incretin or enterogastrone?. Gut 2006, 55:148-150.
7. Gromada J., Holst J.J., Rorsman P. Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1. Pflugers Arch 1998, 435:583-594.
8. Vilsboll T., Krarup T., Madsbad S., Holst J.J. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects. Regul Pept 2003, 114:115-121.
9. Gunnarsson P.T., Winzell M.S., Deacon C.F., Larsen M.O., Jelic K., Carr R.D., Ahren B. Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice. Endocrinology 2006, 147:3173-3180.
10. Carr R.D., Larsen M.O., Winzell M.S., Jelic K., Lindgren O., Deacon C.F., Ahren B. Incretin and islet hormonal responses to fat and protein ingestion in healthy men. Am J Physiol Endocrinol Metab 2008, 295:E779-E784.
11. Nauck M.A., Vardarli I., Deacon C.F., Holst J.J., Meier J.J. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?. Diabetologia 2011, 54:10-18.
12. Chen H., Sullivan G., Quon M.J. Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 2005, 54:1914-1925.
13. Mari A., Pacini G., Murphy E., Ludvik B., Nolan J.J. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001, 24:539-548.
14. Berthiaume N., Zinker B.A. Metabolic responses in a model of insulin resistance: comparison between oral glucose and meal tolerance tests. Metabolism 2002, 51:595-598.
15. Bock G., Dalla Man C., Campioni M., Chittilapilly E., Basu R., Toffolo G., Cobelli C., Rizza R. Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes. Diabetes 2007, 56:1113-1119.
16. Rijkelijkhuizen J.M., Girman C.J., Mari A., Alssema M., Rhodes T., Nijpels G., Kostense P.J., Stein P.P., Eekhoff E.M., Heine R.J., Dekker J.M. Classical and model-based estimates of beta-cell function during a mixed meal vs. an OGTT in a population-based cohort. Diabetes Res Clin Pract 2009, 83:280-288.
17. Kanauchi M., Kimura K., Kanauchi K., Saito Y. Beta-cell function and insulin sensitivity contribute to the shape of plasma glucose curve during an oral glucose tolerance test in non-diabetic individuals. Int J Clin Pract 2005, 59:427-432.
18. Nesher R., Cerasi E. Biphasic insulin release as the expression of combined inhibitory and potentiating effects of glucose. Endocrinology 1987, 121:1017-1024.
19. Rorsman P., Eliasson L., Renstrom E., Gromada J., Barg S., Gopel S. The cell physiology of biphasic insulin secretion. News Physiol Sci 2000, 15:72-77.
20. Gerich J.E. Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?. Diabetes 2002, 51(Suppl. 1):S117-S121.
21. Mitrakou A., Kelley D., Mokan M., Veneman T., Pangburn T., Reilly J., Gerich J. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 1992, 326:22-29.
22. Carr R.D., Larsen M.O., Jelic K., Lindgren O., Vikman J., Holst J.J., Deacon C.F., Ahren B. Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men. J Clin Endocrinol Metab 2010, 95:872-878.
23. Rijkelijkhuizen J.M., McQuarrie K., Girman C.J., Stein P.P., Mari A., Holst J.J., Nijpels G., Dekker J.M. Effects of meal size and composition on incretin, alpha-cell, and beta-cell responses. Metabolism 2010, 59:502-511.
24. Vilsboll T., Krarup T., Sonne J., Madsbad S., Volund A., Juul A.G., Holst J.J. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 2003, 88:2706-2713.
25. Yamazaki K., Inoue T., Yasuda N., Sato Y., Nagakura T., Takenaka O., Clark R., Saeki T., Tanaka I. Comparison of efficacies of a dipeptidyl peptidase IV inhibitor and alpha-glucosidase inhibitors in oral carbohydrate and meal tolerance tests and the effects of their combination in mice. J Pharmacol Sci 2007, 104:29-38.
26. Dangin M., Boirie Y., Garcia-Rodenas C., Gachon P., Fauquant J., Callier P., Ballevre O., Beaufrere B. The digestion rate of protein is an independent regulating factor of postprandial protein retention. Am J Physiol Endocrinol Metab 2001, 280:E340-E348.
27. Stein D.T., Stevenson B.E., Chester M.W., Basit M., Daniels M.B., Turley S.D., McGarry J.D. The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 1997, 100:398-403.
28. von Post-Skagegard M., Vessby B., Karlstrom B. Glucose and insulin responses in healthy women after intake of composite meals containing cod-, milk-, and soy protein. Eur J Clin Nutr 2006, 60:949-954.
29. Ayala J.E., Bracy D.P., McGuinness O.P., Wasserman D.H. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 2006, 55:390-397.
30. Andrikopoulos S., Blair A.R., Deluca N., Fam B.C., Proietto J. Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab 2008, 295:E1323-E1332.
31. Kwiatek M.A., Menne D., Steingoetter A., Goetze O., Forras-Kaufman Z., Kaufman E., Fruehauf H., Boesiger P., Fried M., Schwizer W., Fox M.R. Effect of meal volume and calorie load on postprandial gastric function and emptying: studies under physiological conditions by combined fiber-optic pressure measurement and MRI. Am J Physiol Gastrointest Liver Physiol 2009, 297:G894-G901.
32. Pilichiewicz A.N., Chaikomin R., Brennan I.M., Wishart J.M., Rayner C.K., Jones K.L., Smout A.J., Horowitz M., Feinle-Bisset C. Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men. Am J Physiol Endocrinol Metab 2007, 293:E743-E753.
33. Edelbroek M., Horowitz M., Fraser R., Wishart J., Morris H., Dent J., Akkermans L. Adaptive changes in the pyloric motor response to intraduodenal dextrose in normal subjects. Gastroenterology 1992, 103:1754-1761.
34. Brandt A., Katschinski M., Arnold R., Polonsky K.S., Goke B., Byrne M.M. GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve. Am J Physiol Endocrinol Metab 2001, 281:E242-E247.
35. Reimann F., Gribble F.M. Glucose-sensing in glucagon-like peptide-1-secreting cells. Diabetes 2002, 51:2757-2763.
36. Matsumura K., Miki T., Jhomori T., Gonoi T., Seino S. Possible role of PEPT1 in gastrointestinal hormone secretion. Biochem Biophys Res Commun 2005, 336:1028-1032.
37. Reimann F., Williams L., da Silva Xavier G., Rutter G.A., Gribble F.M. Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells. Diabetologia 2004, 47:1592-1601.
38. Edfalk S., Steneberg P., Edlund H. Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion. Diabetes 2008, 57:2280-2287.
39. Hirasawa A., Tsumaya K., Awaji T., Katsuma S., Adachi T., Yamada M., Sugimoto Y., Miyazaki S., Tsujimoto G. Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120. Nat Med 2005, 11:90-94.
40. Ma J., Stevens J.E., Cukier K., Maddox A.F., Wishart J.M., Jones K.L., Clifton P.M., Horowitz M., Rayner C.K. Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care 2009, 32:1600-1602.
41. Thomas C., Gioiello A., Noriega L., Strehle A., Oury J., Rizzo G., Macchiarulo A., Yamamoto H., Mataki C., Pruzanski M., Pellicciari R., Auwerx J., Schoonjans K. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009, 10:167-177.
42. Anini Y., Hansotia T., Brubaker P.L. Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats. Endocrinology 2002, 143:2420-2426.
43. Rocca A.S., Brubaker P.L. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 1999, 140:1687-1694.